OTLK
Outlook Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Outlook Therapeutics (OTLK) Stock: Buy, Sell, or Hold?
$0.40
-0.02 (-4.04%)
▼
5d:
-13.72%
30d:
-18.82%
90d:
-43.39%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$0.44 – $0.55
Position: OVERSOLD
Forward P/E & Valuation
-3.4x
Next 12M consensus est.
Wall Street Target
$5.03
+1116.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.41 / $0.50
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: OTLK is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When OTLK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: OTLK is currently trading at $0.40, which is considered oversold relative to its 30-day fair value range of $0.44 to $0.55.
Technical Outlook: Technically, OTLK is in a strong downtrend. The price is currently testing key support at $0.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: OTLK scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.03 (+1116.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OTLK is in a strong downtrend. The price is currently testing key support at $0.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: OTLK scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.03 (+1116.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.44 -
$0.55
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$0.44 -
$0.55
Current vs Trading Range
OVERSOLD
Support Level
$0.41
Resistance Level
$0.50
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
103d (53% conf)
30D Insider Cluster Signal
CLUSTER BUY
30D Insider Buyers:
4 insiders ($2,599,996)
30D Net Insider Flow:
+$2,599,996
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 1116.7% below Wall St target ($5.03)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.44
Wall Street Target
$5.03
(+1116.7%)
Revenue Growth (YoY)
-99.4%
Share OTLK Analysis
Share this live OTLK analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (OTLK)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 16, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish sentiment towards $OTLK following the announcement of a price reduction for Lucentis, a competing drug. The OTLK team is expected to adjust their marketing strategy.
Key Retail Themes:
Competition
Marketing Strategy
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 1:53 PM ET
Data refreshes hourly during market hours. Next update: 2:53 PM
Data refreshes hourly during market hours. Next update: 2:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OTLK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 54 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 51 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive OTLK Research Pages
OTLK Technical Chart
OTLK Price Prediction
OTLK Intrinsic Value DCF
OTLK Earnings Date
OTLK Investment Advisor
OTLK Fair Price Analyzer
OTLK Target Price Playground
OTLK LEAP Simulator
OTLK Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
OTLK Competitors
Part B: Tradestie Flagship Market Scanners